Bradbury Daniel's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Dec 12, 2023
- Accession no.
- 0001447362-23-000171
- Filed
- Dec 12, 2023
- Trade date
- Dec 8, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $138.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bradbury DanielCIK 0001236397 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2023 | Common Stock | SSaleDisposed | −2,179 | $20.09F2 | −$43,776.11 | 72,838 | Indirect | |
| Dec 8, 2023 | Common Stock | SSaleDisposed | −2,347 | $20.09F2 | −$47,151.23 | 50,605 | Indirect | |
| Dec 8, 2023 | Common Stock | SSaleDisposed | −2,349 | $20.09F2 | −$47,191.41 | 50,625 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.00 to $20.20, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.